Ligand validation:7E6Z

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 7E6Z designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7E6Z_OLC_A_410	14%	90%	0.155	0.831	0.32	0.28	-	-	0	0	32%	0.32
7E6Z_OLC_A_409	8%	92%	0.186	0.779	0.36	0.17	-	-	0	0	36%	0.36
7E6Z_OLC_A_402	1%	80%	0.324	0.552	0.41	0.44	-	-	3	0	100%	1
7E6Z_OLC_A_403	1%	78%	0.314	0.596	0.41	0.47	-	-	0	0	64%	0.64
7E6Z_OLC_A_406	1%	88%	0.369	0.603	0.3	0.37	-	-	0	0	72%	0.72
7E6Z_OLC_A_405	1%	88%	0.353	0.565	0.29	0.37	-	-	0	0	64%	0.64
7E6Z_OLC_A_404	1%	90%	0.358	0.542	0.31	0.3	-	-	0	0	56%	0.56
7E6Z_OLC_A_407	1%	86%	0.297	0.507	0.35	0.36	-	-	1	0	40%	0.4
7E6Z_OLC_A_408	0%	86%	0.48	0.058	0.4	0.32	-	-	0	0	40%	0.4
7E71_OLC_A_410	18%	92%	0.138	0.848	0.34	0.18	-	-	0	0	32%	0.32
7E6Y_OLC_A_405	14%	68%	0.205	0.817	0.57	0.65	-	-	0	0	64%	0.64
7E6X_OLC_A_410	12%	90%	0.156	0.81	0.35	0.27	-	-	0	0	32%	0.32
7E70_OLC_A_404	6%	89%	0.279	0.798	0.26	0.38	-	-	0	0	56%	0.56
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	2	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	0.88
5IU4_OLC_A_2429	61%	59%	0.136	0.926	0.8	0.78	2	1	1	0	100%	1
6G7H_OLC_A_310	61%	92%	0.117	0.905	0.26	0.26	-	-	0	0	100%	1
7B0O_OLC_A_302	59%	54%	0.146	0.929	0.69	1.07	1	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.